FDAnews Drug Daily Bulletin

INTELLIPHARMACEUTICS AND LARASAN PHARMACEUTICAL AGREE TO NDA PROGRAM FOR CONTROLLED RELEASE ANALGESIC

May 3, 2006
A A

IntelliPharmaCeutics Corp., a Canadian specialty pharmaceutical company, the operating affiliate of IntelliPharmaCeutics Ltd., (Delaware), is pleased to announce that it has entered into a new agreement with Larasan Pharmaceutical Corporation, a Florida corporation, for the development of a controlled release analgesic product for the United States and worldwide markets. Financial terms of the agreement were not disclosed. Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20060502005373&newsLang=en)